Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
's Business Segments
's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
2
Largest Segment
Retail
Total Revenue
$ 23
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Retail0%
- Wholesale6.5%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Retail | $ 42 | - |
| Wholesale | $ 1 | 6.5% |
Annual Results
Revenue Share by Reportable Segment - FY
- Retail0%
- Wholesale6.5%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Retail | $ 42 | - |
| Wholesale | $ 1 | 6.5% |
Description of
Planet 13 Holdings Inc., through its wholly-owned subsidiaries, operates in the cannabis industry. The company qualifies as an emerging growth company under the Securities Act and the JOBS Act, which provides certain reduced disclosure requirements and exemptions. Planet 13 is involved in the acquisition, cultivation, production, and sale of cannabis products. Its growth strategy includes expanding into new markets, opening new dispensaries, applying for additional licenses, and completing cultivation and production facilities currently under construction. The company also anticipates benefits from its acquisition of VidaCann, LLC. Planet 13 faces risks related to regulatory compliance, competition, dependence on limited jurisdictions, agricultural operational challenges, cybersecurity threats, and potential litigation. The company focuses on managing growth, maintaining licenses, and navigating regulatory frameworks in the U.S. and Canada. Its operations include manufacturing cannabis products for human consumption with an emphasis on quality control and compliance. Forward-looking statements address expectations for market growth, business development, and potential changes in U.S. federal cannabis laws.
The Company operates as a single segment, focusing on the cultivation, production, and sale of cannabis products for medicinal and adult use in accordance with state laws and regulations. The Co-Chief Executive Officers, serving as the chief operating decision makers, monitor the Company's consolidated operating performance using metrics such as revenue, adjusted EBITDA, and cash provided by operating activities. They also review significant expenses, including cost of goods sold, sales and marketing expenses, and general and administrative expenses. As of December 31, 2025 and 2024, all assets and 100% of revenue were located and generated within the United States.
